Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1993 May;61(5):2216–2219. doi: 10.1128/iai.61.5.2216-2219.1993

Lipopolysaccharide restores anti-Candida albicans growth inhibition activity of polymorphonuclear neutrophils from retrovirus-immunosuppressed mice.

Y Yamamoto 1, S Specter 1, H Friedman 1
PMCID: PMC280826  PMID: 8478114

Abstract

It has been documented that the immune function of leukocytes may be markedly suppressed after infection of mice with the murine retrovirus Friend leukemia virus (FLV). Antimicrobial activity of polymorphonuclear neutrophils (PMNs) against Candida albicans is impaired after retrovirus infection of mice, and this occurs as early as 3 days after infection of genetically susceptible BALB/c mice. By 2 weeks after infection, there was essentially very little growth inhibition of C. albicans by PMNs from the FLV-infected mice. However, when bacterial lipopolysaccharide (LPS), a known activator of macrophages and PMNs, was added to PMNs from the FLV-infected mice, anti-C. albicans activity was restored to normal levels. This restoration of anti-C. albicans activity of FLV-infected mouse PMNs was observed after stimulation with as little as 0.01 micrograms of LPS per ml. The data obtained show that the impaired antimicrobial function of PMNs from retrovirus-infected mice can be readily restored by a biological response modifier such as bacterial LPS.

Full text

PDF
2216

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson J. S., Mills E. L. Depression of neutrophil function induced by viruses and its role in secondary microbial infections. Rev Infect Dis. 1988 Mar-Apr;10(2):326–341. doi: 10.1093/clinids/10.2.326. [DOI] [PubMed] [Google Scholar]
  2. Bendinelli M., Matteucci D., Friedman H. Retrovirus-induced acquired immunodeficiencies. Adv Cancer Res. 1985;45:125–181. doi: 10.1016/s0065-230x(08)60268-7. [DOI] [PubMed] [Google Scholar]
  3. Brummer E., Sugar A. M., Stevens D. A. Enhanced oxidative burst in immunologically activated but not elicited polymorphonuclear leukocytes correlates with fungicidal activity. Infect Immun. 1985 Aug;49(2):396–401. doi: 10.1128/iai.49.2.396-401.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chesebro B., Wehrly K., Cloyd M., Britt W., Portis J., Collins J., Nishio J. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens. Virology. 1981 Jul 15;112(1):131–144. doi: 10.1016/0042-6822(81)90619-x. [DOI] [PubMed] [Google Scholar]
  5. Dent P. B. Immunodepression by oncogenic viruses. Prog Med Virol. 1972;14:1–35. [PubMed] [Google Scholar]
  6. Djeu J. Y., Blanchard D. K., Halkias D., Friedman H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol. 1986 Nov 1;137(9):2980–2984. [PubMed] [Google Scholar]
  7. Djeu J. Y., Blanchard D. K. Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. J Immunol. 1987 Oct 15;139(8):2761–2767. [PubMed] [Google Scholar]
  8. Djeu J. Y., Blanchard D. K., Richards A. L., Friedman H. Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol. 1988 Dec 1;141(11):4047–4052. [PubMed] [Google Scholar]
  9. Djeu J. Y., Parapanissios A., Halkias D., Friedman H. A rapid [3H]glucose incorporation assay for determination of lymphoid cell-mediated inhibition of Candida albicans growth. J Immunol Methods. 1986 Aug 21;92(1):73–77. doi: 10.1016/0022-1759(86)90505-3. [DOI] [PubMed] [Google Scholar]
  10. Dracott B. N., Wedderburn N., Salaman M. H. In vitro immune responses of spleen cells from Friend virus infected mice. J Gen Virol. 1972 Jan;14(1):77–86. doi: 10.1099/0022-1317-14-1-77. [DOI] [PubMed] [Google Scholar]
  11. Lazzarin A., Uberti Foppa C., Galli M., Mantovani A., Poli G., Franzetti F., Nóvati R. Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome. Clin Exp Immunol. 1986 Jul;65(1):105–111. [PMC free article] [PubMed] [Google Scholar]
  12. Lopez-Cepero M., Specter S., Matteucci D., Friedman H., Bendinelli M. Altered interleukin production during Friend leukemia virus infection. Proc Soc Exp Biol Med. 1988 Jul;188(3):353–363. doi: 10.3181/00379727-188-42746. [DOI] [PubMed] [Google Scholar]
  13. Matteucci D., Giangregorio A. M., Lopez-Cepero M., Specter S., Bendinelli M., Friedman H. Interleukins 1 and 2 production and responsiveness in the early stages of retroviral infections of mice. Cell Immunol. 1989 Apr 15;120(1):10–20. doi: 10.1016/0008-8749(89)90170-6. [DOI] [PubMed] [Google Scholar]
  14. Moors M. A., Jones S. M., Klyczek K. K., Rogers T. J., Buckley H. R., Blank K. J. Effect of Friend leukemia virus infection on susceptibility to Candida albicans. Infect Immun. 1990 Jun;58(6):1796–1801. doi: 10.1128/iai.58.6.1796-1801.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Morrison C. J., Isenberg R. A., Stevens D. A. Enhanced oxidative mechanisms in immunologically activated versus elicited polymorphonuclear neutrophils: correlations with fungicidal activity. J Med Microbiol. 1988 Feb;25(2):115–121. doi: 10.1099/00222615-25-2-115. [DOI] [PubMed] [Google Scholar]
  16. Morrison D. C., Ryan J. L. Bacterial endotoxins and host immune responses. Adv Immunol. 1979;28:293–450. doi: 10.1016/s0065-2776(08)60802-0. [DOI] [PubMed] [Google Scholar]
  17. Mortensen R. F., Ceglowski W. S., Friedman H. Leukemia virus-induced immunosuppression. IX. Depression of delayed hypersensitivity and MIF production after infection of mice with Friend leukemia virus. J Immunol. 1973 Dec;111(6):1810–1819. [PubMed] [Google Scholar]
  18. Shalaby M. R., Aggarwal B. B., Rinderknecht E., Svedersky L. P., Finkle B. S., Palladino M. A., Jr Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol. 1985 Sep;135(3):2069–2073. [PubMed] [Google Scholar]
  19. Sitbon M., Nishio J., Wehrly K., Lodmell D., Chesebro B. Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses. Virology. 1985 Feb;141(1):110–118. doi: 10.1016/0042-6822(85)90187-4. [DOI] [PubMed] [Google Scholar]
  20. Valone F. H., Payan D. G., Abrams D. I., Goetzl E. J. Defective polymorphonuclear leukocyte chemotaxis in homosexual men with persistent lymph node syndrome. J Infect Dis. 1984 Aug;150(2):267–271. doi: 10.1093/infdis/150.2.267. [DOI] [PubMed] [Google Scholar]
  21. Wedderburn N., Salaman M. H. The immunodepressive effect of Friend virus. II. Reduction of splenic haemolysin-producing cells in primary and secondary responses. Immunology. 1968 Sep;15(3):439–454. [PMC free article] [PubMed] [Google Scholar]
  22. Weisbart R. H., Golde D. W., Clark S. C., Wong G. G., Gasson J. C. Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. 1985 Mar 28-Apr 3Nature. 314(6009):361–363. doi: 10.1038/314361a0. [DOI] [PubMed] [Google Scholar]
  23. Weislow O. S., Friedman H., Wheelock E. F. Suppression of established Friend virus leukemia by statolon. V. Reversal of virus-induced immunodepression to sheep erythrocytes. Proc Soc Exp Biol Med. 1973 Feb;142(2):401–405. doi: 10.3181/00379727-142-37032. [DOI] [PubMed] [Google Scholar]
  24. Zunich K. M., Lane H. C. Immunologic abnormalities in HIV infection. Hematol Oncol Clin North Am. 1991 Apr;5(2):215–228. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES